Issue 01 · Evidence & marketing

The supplement industry ships marketing copy. We ship receipts.

Every week we take a top-selling supplement apart ingredient by ingredient, cross-reference the claims against published research, and tell you whether the bottle is worth your money — or a rebill trap with a clever landing page.

01

We read the paper, not the press release.

Every claim gets traced to a published study. When the study doesn't say what the label says, we say so.

02

Dose matters. Blends hide it.

Proprietary blends let brands hide clinically-irrelevant doses. We estimate the real dose range every time.

03

Rebills are a feature, not a bug.

We flag auto-ship traps, cancellation friction, and the checkout tricks designed to inflate lifetime value.